DarioHealth Corp. announced on October 30, 2024, a new contract with a regional health plan operating in the Medicaid sector. This agreement immediately launched with Dario's full suite of cardiometabolic solutions. This marks Dario's third Medicaid client, demonstrating continued momentum in this market segment.
The health plan selected Dario based on the company's track record of driving engagement among diverse populations. The initial pilot program will serve nearly 10,000 Medicaid members. Dario's approach to personalized member experiences across various channels is particularly attractive to Medicaid plans, which often manage members with limited access to traditional healthcare.
Steven Nelson, Chief Commercial Officer at Dario, stated that this contract highlights the company's ability to engage historically hard-to-reach Medicaid populations. He also noted that this new relationship is estimated to contribute to revenues in the fourth quarter of 2024, with further expansion opportunities in this market segment planned for 2025.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.